Shanhu Hu

Senior Scientist, Syros Pharmaceuticals Inc., Cambridge, Massachusetts

Biology lead in small molecule oncology preclinical development project targeting CDK12/13 and CDK7, responsible for target validation, compound structure-activity relationships (SAR) optimization, novel cellular assays development, mechanism of action (MOA) study design, in vivo PK/PD/efficacy study design, biomarker discovery, and combination treatment strategy development.


  • PhD, '15, Program in Experimental and Molecular Medicine at Dartmouth
  • BS, '10, Fudan University


Dartmouth Graduate Student Travel Award, 2014

Top Poster, Dartmouth Integrative Biology Symposium, 2014